Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Announcement & Circular
Stock Information
02186.HK
2.72 0.02  (0.74%)
TradingVolume：2512.56
08-02
2018
Announcement Made Pursuant to Rule 13.18 oftThe Listing Rules
Publisher：
08-02
2018
Monthly Return of Equity Issuer on Movements in Securities for the month Ended 31 July 2018
Publisher：
07-31
2018
Voluntary Announcement - Approval for Clinical Trial for Class I New Chemical Drug - Anti-tumor Innovative Drug (LY01013) in China
Publisher：
07-25
2018
Environmental, Social and Governance Report 2017
Publisher：
07-19
2018
Voluntary Announcement - Approval of New Indication for Seroquel XR in China
Publisher：
06-28
2018
Major Transaction in Relation to Acquisition of Astrazeneca's Rights Relating to Seroquel and Seroquel XR in China and in other Territories
Publisher：
06-22
2018
Poll Results of Special General Meeting Held on 22 June 2018
Publisher：
06-22
2018
Announcement Made Pursuant to Rule 13.18 of the Listing Rules
Publisher：
06-20
2018
Voluntary Announcement - Rotigotine Extended Release Microspheres for Injection (LY03003) Commenced Phase III Clinical Trial in China
Publisher：
06-15
2018
Clinical Application of Class 1.1 New Chemical Drug LY03012 was Formally Accepted
Publisher：
First
28
29
30
31
32
Last
Investors
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Stock Information
02186.HK
TradingVolume：2512.56
2.72
0.02  (0.74%)
Announcement & Circular
08-02
2018
Announcement Made Pursuant to Rule 13.18 oftThe Listing Rules
08-02
2018
Monthly Return of Equity Issuer on Movements in Securities for the month Ended 31 July 2018
07-31
2018
Voluntary Announcement - Approval for Clinical Trial for Class I New Chemical Drug - Anti-tumor Innovative Drug (LY01013) in China
07-25
2018
Environmental, Social and Governance Report 2017
07-19
2018
Voluntary Announcement - Approval of New Indication for Seroquel XR in China
06-28
2018
Major Transaction in Relation to Acquisition of Astrazeneca's Rights Relating to Seroquel and Seroquel XR in China and in other Territories
06-22
2018
Poll Results of Special General Meeting Held on 22 June 2018
06-22
2018
Announcement Made Pursuant to Rule 13.18 of the Listing Rules
06-20
2018
Voluntary Announcement - Rotigotine Extended Release Microspheres for Injection (LY03003) Commenced Phase III Clinical Trial in China
06-15
2018
Clinical Application of Class 1.1 New Chemical Drug LY03012 was Formally Accepted
First
28
29
30
31
32
Last